Effects of Vascular Endothelial Growth Factor-Sirna on Apoptosis and Vasculo-Genic Mimicry of Osteosarcoma Cells
ZHANG Li-zhi,CAI Xuan-song,QIAN Zhi-kang,MEI Jiong,HUANG Huang-yuan,HUANG Wei-da
DOI: https://doi.org/10.3872/j.issn.1007-385x.2007.04.011
2007-01-01
Abstract:Objective: To study the role of vascular endothelial growth factor (VEGF)-siRNA in the proliferation, apoptosis, and vasculogenic mimicry of osteosarcoma cell line MG63. Methods: pSilencer vector was used to construct pSilencer-VEGF siRNA and the latter was used to transfect MG63 cells (experimental group). MG63 cells were also transfected with blank SiRNA to serve as control (control group). Western blotting was used to examine the expression of VEGF protein in MG63 cells in the 2 groups. The proliferation, apoptosis, and vasculogenic mimicry of MG63 cells were investigated using MTT assay, light microscope, and flow cytometry combined with Annexin V-FITC/PI and H-E staining. Results: The pSilencer-VEGF plasmid was confirmed by DNA sequencing. Sequence-specific siRNA targeting VEGF significantly decreased the expression of VEGF protein expression in MG63 cells. 48, 72 and 96 hours after pSilencer-VEGF-siRNA transfection, the inhibitory rate of MG63 cells proliferation were 41.67%, 43.92%, and 35.32%, respectively. Early apoptosis was also noticed in MG63 cells, with an apoptosis rate of 28.27%. Vasculogenic mimicry of MG63 cells was not found in experimental group, but was noticed in control group. Conclusion: Sequence-specific siRNA targeting VEGF can inhibit the proliferation, promote early apoptosis, and interfere with the vasculogenic mimicry of osteosarcoma cells, which casts new lights on clinical treatment of osteosarcoma.